Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review (Nov 2012) The Annals of Internal Medicine compares the benefits and harms of antiviral regimens for chronic HCV infection in treatment-naive adults.
Screening for Hepatitis C Virus Infection in Adults: A Systematic Review to Update the 2004 U.S. Preventative Services Task Force Recommendation (Nov 2012) The Annals of Internal Medicine reviews evidence about potential benefits and harms of HCV screening in asymptomatic adults without known liver enzyme abnormalities.
Recommendations for Standardized Nomenclature and Definitions of Viral Responses in Trials of HCV Investigational Agents (PDF) The Hepatitis C Virus Drug Development Advisory Group, the American Association of Liver Diseases, European Association for the Study of Liver Diseases, and IDSA collaborated to develop a standardized descriptive, virologic response nomenclature for key decision points in trials.
Combating the Silent Epidemic of Viral Hepatitis: Year 1 Progress Report (PDF) The US Department of Health and Human Services' Viral Hepatitis Action Plan details more than 150 actions to be undertaken over the course of several years by agencies and offices across HHS and partners at the Federal Bureau of Prisons and the US Department of Veterans Affairs that will improve the prevention, diagnosis, and treatment of viral hepatitis in the United States. This report highlights the progress made during the first year of implementing the Action Plan.
Centers for Disease Control and Prevention, Viral Hepatitis Statistics & Surveillance 2010 A 2010 report that provides statistical data for all cases of hepatitis reported to the National Notifiable Disease Surveillance System (NNDSS).
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2017 Infectious Diseases Society of America